Optimal Non-invasive Brain Stimulation for Peripheral Vision

Recruiting N/A Interventional Study
Glaucoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
The Hong Kong Polytechnic University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Glaucoma is a complex disease that can result in progressive vision loss. There are no treatments that restore vision lost to glaucoma. However, recent studies have shown that vision can be improved by non-invasive brain (NIBS) stimulation and visual training. In this study, we aim to compare and find out the optimal non-invasive brain stimulation model (transcranial direct current stimulation (tD…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age range from 18 to 80 years; 2. Diagnosis of primary open angle or normal tension glaucoma with relative scotoma in both eyes; 3. A relative scotoma defined as a Humphrey Field Analyser (HFA) threshold perimetry loss (mean deviation of ≤-6dB) within the central 30° of the v…
Contacts

Allen Cheong, PhD

852-27666108

allen.my.cheong@polyu.edu.hk

CONTACT

Ben Thompson, PhD

852-27666108

ben.thompson@uwaterloo.ca

CONTACT